Urging the agency to update federal regulations governing the use and interstate sale of certain hemp-derived ingredients.
This document is page 76 of a Cowen Collaborative Insights report dated February 25, 2019. It details regulatory challenges and updates regarding CBD and hemp products, specifically focusing on FDA regulations and state-level legislation in California (Assembly Bill 2914). The document bears a 'HOUSE_OVERSIGHT' footer, suggesting it was part of a document production for a congressional investigation, though the content itself is strictly related to cannabis industry regulation and contains no direct mention of Jeffrey Epstein or his associates.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein communication